Skip to content
Lower risk Drug recall · FDA · Published April 24, 2020

Harvard Drug Group Memantine Capsules Recall: Failed Dissolution Testing

Harvard Drug Group recalls 28mg Memantine Hydrochloride Extended-Release Capsules due to failed dissolution testing in stability checks. This affects Rx-only products with specific NDC and lot numbers.

🇺🇸 FDA recall #D-1262-2020DrugThe Harvard Drug Group ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group17177 N Laurel Park Dr Ste 233 · Livonia, MI 48152-3951
✎ GovInfoNow plain-language explainer

The Harvard Drug Group is recalling 28 mg Memantine Hydrochloride Extended-Release Capsules because they failed dissolution testing during stability checks. This means the medication may not release properly in the body, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/37132-harvard-drug-group-memantine-capsules-recall-failed-dissolution-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/37132-harvard-drug-group-memantine-capsules-recall-failed-dissolution-testing · Updated October 5, 2026 · FDA enforcement record: FDA #D-1262-2020

Cite this page

“Harvard Drug Group Memantine Capsules Recall: Failed Dissolution Testing.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37132-harvard-drug-group-memantine-capsules-recall-failed-dissolution-testing. Based on FDA recall #D-1262-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1262-2020%22&limit=1).

The Food and Drug Administration announced on April 24, 2020, that The Harvard Drug Group voluntarily recalled Memantine Hydrochloride Extended-Release Capsules due to failed dissolution specifications. The recall involves 678 cartons distributed in Alabama, Florida, Iowa, New York, Ohio, and Texas.

How to tell if you have it

  • Brand: The Harvard Drug Group
  • Product: Memantine Hydrochloride Extended-Release Capsules, 28 mg
  • Packaging: 100 capsules per unit dose cartons
  • NDC: 0904-6735-61
  • Lot codes: M02199D, M02246D
  • Expiration date: May 2020
  • Quantity: 678 cartons

The hazard

The recall was initiated because the product failed dissolution specifications, with low stage 3 results obtained during routine stability testing. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show The Harvard Drug Group has 20 other recalls on record since July 15, 2016. Other recent recalls of similar products include Harvard Drug Group Recalls Tramadol Tablets Due to Packaging Defect (June 16, 2023) and Harvard Drug Group Recalls Gabapentin Tablets Due to Foreign Tablet Mixup (April 24, 2023). Additional context includes the Sun Pharmaceutical Lisdexamfetamine Capsules Recall regarding failed dissolution tests on October 28, 2025.

How to tell if you have this one

Check for NDC number 0904-6735-61 and lot numbers M02199D or M02246D with expiration date 5/2020. The product is prescription-only and sold in 100-capsule cartons.

  • Brand
    The Harvard Drug Group
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC number 0904-6735-61 and lot numbers M02199D or M02246D with expiration date 5/2020.

Where it went and when

Where it was distributed

Distributed in 6 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: yesIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: yesALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: yesFL

FDA distribution: “AL, FL, IA, NY, OH, TX” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alabama, Florida, Iowa, New York, Ohio, Texas.

Recall timeline

FDA terminated this recall 2.3 years after the firm started it.

1. Firm started the recall: Apr 24, 202012. FDA classified it Class III: May 13, 202023. Published in FDA’s Enforcement Report: May 20, 202034. FDA terminated the recall: Aug 19, 2022420202022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1262-2020 (April 24, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1262-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA